All eyes are on Thomas Flanagan, a former Deloitte VP who resigned a few weeks back, rather abruptly. On October 29th Delottie filed suit against Flanagan for allegedly buying stock in an unnamed company (Option Care, Inc.) just a week before a Deloitte client (Walgreens) announced their acquisition of the firm.

Deloitte had been the auditing firm contracted to review the deal. Falanaga had been the Deloitte client contact on the matter. In their lawsuit Deloitte claims ignorance of this an other questionable conduct on Flanagan's part - at least until regulators began asking them questions.

For more on the Flanagan case, check out The Chicago Tribune.

-- MDT

Labels: Deloitte, insider trading, Thomas Flanagan